References
- Rosso M, Chitnis T. Association between cigarette smoking and multiple sclerosis. A review. JAMA Neurol. 2019 Dec 16. Epub ahead of print.
- Manouchehrinia A, Tench CR, Maxted J, et al. Tobacco smoking and disability progression in multiple sclerosis: a United Kingdom cohort study. Brain. 2013;136:2298–2304.
- Ramanujam R, Hedström AK, Manouchehrinia A, et al. Effect of smoking cessation on multiple sclerosis prognosis. JAMA Neurol. 2015;72:1117–1123.
- Tanasescu R, Constantinescu CS, Tench CR, et al. Smoking cessation and the reduction of disability progression in multiple sclerosis: a cohort study. Nicotine Tob Res. 2018;20:589–595.
- Hedström AK, Ryner M, Fink K, et al. Smoking and risk of treatment-induced antibodies to interferon β-1a. Mult Scler. 2014;20:445–450.
- Koch M, van Harten A, Uyttenboogaart M, et al. Cigarette smoking and progression in multiple sclerosis. Neurology. 2007;69:1515–1520.
- Kvistad S, Myhr KM, Holmoy T, et al. No association of tobacco use and disease activity in multiple sclerosis. Neurol Neuroimmun Neuroinflamm. 2016;3:e260.
- Gao Z, Nissen JC, Ji K, et al. The experimental autoimmune encephalomyelitis disease course is modulated by nicotine and other cigarette smoke components. PLoS One. 2014;9:e107979.
- D’hooghe MB, Haentiens NG, De Keyser J. Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis. Eur J Neurol. 2012;19:616–624.
- Javizian O, Metz LM, Deighton S, et al. Smoking does not influence disability accumulation in primary progressive multiple sclerosis. Eur J Neurol. 2017;24(4):624–630.
- Smith KJ, Kapoor R, Hall SM, et al. Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol. 2001;49:470–476.
- Rejdak K, Eikelenboom MJ, Petzold A, et al. CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis. Neurology. 2004;63(8):1439–1445.
- van Houten WH, Friede R. Histochemical studies of experimental demyelination produced with cyanide. Exp Neurol. 1961;4(5):402–412.
- Mouhamed DH, Azzaher A, Neffati F, et al. Effect of cigarette smoking on plasma uric acid concentrations. Environ Health Prev Med. 2011;16(5):307–312.
- Moccia M, Lanzillo R, Costabile T, et al. Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study. J Neurol. 2015;262(4):961–967.
- Qiu F, Liang CL, Liu H, et al. Impacts of cigarette smoking on immune responsiveness: up and down or upside down? Oncotarget. 2017;8:268–284.
- Buljevac D, Flach HZ, Hop WC, et al. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain. 2002;125:952–960.
- Marrie RA, Rudick R, Horwitz R, et al. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology. 2010;74:1041–1047.
- Tettey P, Simpson S Jr, Bruce V, et al. Vascular comorbidities in the onset and progression of multiple sclerosis. J Neurol Sci. 2014;347:23–33.
- Moccia M, Lanzillo R, Palladino GT, et al. The Framingham cardiovascular risk score in multiple sclerosis. Eur J Neurol. 2015;22:1176–1183.
- Marrie RA, Horwitz RI, Cutter G, et al. Smokers with multiple sclerosis are more likely to report comorbid autoimmune diseases. Neuroepidemiology. 2011;36:85–90.
- Dopkins N, Nagarkatti PS, Nagarkatti M. The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders. Immunology. 2018;154:178–185.
- Joehanes R, Just AC, Marioni RE, et al. Epigenetic signatures of cigarette smoking. Circ Cardiovasc Genet. 2016;9:436–447.
- Kaur G, Begum R, Thota S, et al. A systematic review of smoking-related epigenetic alterations. Arch Toxicol. 2019;93:2715–2740.